Skip to content

Grand Roundup: Top posts for week of Nov. 16

The five most-read stories this week on Scope were:

My last promises to her: Advocate for lung cancer awareness and live life to the fullest: In the latest installment of our patient-penned Inspire series, a California man talks about becoming a patient advocate after a lung-cancer diagnosis.

Stanford anesthesiologist explores consciousness – and unconsciousness: Anesthesiologist Divya Chander, MD, PhD, is one of a leading group of neuroscientists and anesthesiologists who are using high-tech monitoring equipment in the operating room to explore the nature of consciousness. She discusses her work in this Q&A.

Learning the pelvic exam with Project Prepare: In this piece, part of the SMS Unplugged series, Hamsika Chandrasekar discusses how a group of patient/educators is teaching medical students the art of performing a delicate exam.

Tackling the stigma of lung cancer – and showing the real faces of the disease: After learning that the first question typically asked of lung cancer patients is “Did you smoke?” Janet Freeman-Daily set out to help change public perception of her disease.

Big data approach identifies new stent drug that could help prevent heart attacks: By using a “big data” computational approach, learning about the genetic pathways involved in coronary artery disease, then testing the new theories on mice models in the lab, researchers at Stanford and Columbia were able to pinpoint a potential new treatment for patients who need stents.

And still going strong – the most popular post from the past:

What are the consequences of sleep deprivation?: Brandon Peters, MD, an adjunct clinical faculty member at the Stanford Center for Sleep Sciences and Medicine, explains how lack of sleep can negatively affect a person’s well-being in this Huffington Post piece.

Popular posts

Category:
Biomedical research
Stanford immunologist pushes field to shift its research focus from mice to humans

Much of what we know about the immune system comes from experiments conducted on mice.  But lab mice are not little human beings. The two species are separated by both physiology and  lifestyles. Stanford immunologist Mark Davis is calling on his colleagues to shift their research focus to people.